Left Atrial Appendage Closure for Stroke Risk Reduction in Non-valvular Atrial Fibrillation Offers Clinical and Economic Value
Guest Post from Kenneth Stein, MD, FACC, FHRS Chief Medical Officer Rhythm Management Division at Boston Scientific Corporation, a global medical technology company which manufactures the Watchman LAAC Device. Atrial fibrillation (AF) affects nearly nine percent of all Medicare beneficiaries and represents a significant source of stroke burden.[i] AF patients are five times more likely […]